Table 2.
Structures of tested derivatives and determined concentrations of LC50.
![]() | |||
---|---|---|---|
Compound | R | LC50 (mg/mL) | LC50 (μM) |
I-1 | ![]() |
0.61 | 1.73 |
I-2 | ![]() |
5.04 | 14.16 |
I-3 | ![]() |
very low activity, not specified | very low activity, not specified |
I-4 | ![]() |
4.40 | 11.99 |
![]() | |||
Compound | R | LC50 (mg/mL) | LC50 (μM) |
II-1 | ![]() |
0.30 | 0.90 |
II-2 | ![]() |
3.74 | 11.06 |
II-3 | ![]() |
4.20 | 11.20 |
II-4 | ![]() |
0.75 | 2.15 |
Control | |||
Albendazole | 19.78 | 74.55 |